pravastatin has been researched along with Chronic Illness in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anoopkumar-Dukie, S; Davey, AK; McFarland, AJ | 1 |
| Tonelli, M | 1 |
| Kiefte-de Jong, JC; Nanayakkara, PW; Olthof, MR; Smulders, YM; Stehouwer, CD; Teerlink, T; ter Wee, PM; Twisk, JW; van Guldener, C; van Ittersum, FJ | 1 |
| Brcakova, E; Cermanova, J; Fuksa, L; Hirsova, P; Hyspler, R; Kolouchova, G; Lotkova, H; Micuda, S; Sispera, L; Slanarova, M; Tomsik, P | 1 |
| Nanayakkara, PW; Smulders, YM; Stehouwer, CD; ter Wee, PM; van Guldener, C; van Ittersum, FJ; Vegting, IL; Veringa, SJ | 1 |
| Chow, H; Imagawa, DK; Ji, P; Podnos, Y; Si, MS; Steward, E | 1 |
| Cobbe, SM; Craven, T; Curhan, GC; Furberg, C; Isles, C; Pfeffer, MA; Sacks, FM; Shepherd, J; Simes, J; Tonelli, M; Tonkin, A; West, M | 1 |
| Chiba, S; Goyama, S; Hamaki, T; Hirai, H; Hori, A; Imataki, O; Kami, M; Kanda, Y; Kishi, Y; Kojima, R; Komeno, Y; Makimoto, A; Mitani, K; Ogawa, S; Onishi, Y; Sakiyama, M; Takaue, Y; Tanosaki, R | 1 |
| Hata, T; Ishikawa, K; Kitagawa, Y; Ohta, T; Shinohara, Y; Tomiyasu, H; Yamamoto, M | 1 |
| Cobbe, SM; Craven, T; Curhan, GC; Furberg, C; Isles, C; Packard, C; Pfeffer, MA; Sacks, FM; Shepherd, J; Simes, J; Tonelli, M; Tonkin, A; West, M | 1 |
| Belder, R; Fusco, MJ; Lewis, JH; Medoff, JR; Mortensen, ME; Zweig, S | 1 |
| Angelin, B; Juliusson, G; Vitols, S | 1 |
| Choi-Kwon, S; Kim, JS | 1 |
2 review(s) available for pravastatin and Chronic Illness
| Article | Year |
|---|---|
Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Chronic Disease; Comorbidity; Coronary Disease; Creatinine; Databases, Factual; Double-Blind Method; Drug Evaluation; Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Randomized Controlled Trials as Topic; Risk | 2004 |
Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease.
Topics: Aged; Chronic Disease; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Models, Statistical; Pravastatin; Randomized Controlled Trials as Topic; Renal Insufficiency; Retrospective Studies; Risk | 2005 |
6 trial(s) available for pravastatin and Chronic Illness
| Article | Year |
|---|---|
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
Topics: Adult; Aged; Anticholesteremic Agents; Arginine; Carotid Arteries; Chronic Disease; Creatinine; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Vitamin B 12; Vitamin B 6; Vitamin E | 2009 |
Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on arterial compliance and distensibility in patients with mild-to-moderate chronic kidney disease.
Topics: Adult; Aged; Brachial Artery; Carotid Artery, Common; Chronic Disease; Double-Blind Method; Female; Femoral Artery; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Male; Middle Aged; Pravastatin; Vascular Stiffness; Vitamin E | 2012 |
A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease.
Topics: Chronic Disease; Graft vs Host Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Th1 Cells; Th2 Cells | 2005 |
Effect of anticholesterol therapy on soluble ICAM-1 in chronic stroke patients with hyperlipidemia.
Topics: Aged; Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Female; Humans; Hyperlipidemias; Intercellular Adhesion Molecule-1; Male; Pravastatin; Solubility; Stroke; Triglycerides | 2005 |
Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Double-Blind Method; Female; Humans; Hypercholesterolemia; Liver; Liver Diseases; Male; Middle Aged; Pravastatin; Treatment Outcome; Triglycerides | 2007 |
Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies.
Topics: Adult; Aged; B-Lymphocytes; Cell Division; Cholesterol; Chronic Disease; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Leukemia, Lymphoid; Lipids; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Mitogens; Pravastatin; Simvastatin; Thymidine; Tumor Cells, Cultured | 1997 |
5 other study(ies) available for pravastatin and Chronic Illness
| Article | Year |
|---|---|
Statins Reduce Lipopolysaccharide-Induced Cytokine and Inflammatory Mediator Release in an In Vitro Model of Microglial-Like Cells.
Topics: Anti-Inflammatory Agents; Antioxidants; Atorvastatin; Cell Proliferation; Chronic Disease; Dinoprostone; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Inflammation; Interleukin-1beta; Lipids; Lipopolysaccharides; Microglia; Monocytes; Nitric Oxide; Pravastatin; Quinolines; Reactive Oxygen Species; Rosuvastatin Calcium; Simvastatin; THP-1 Cells; Tumor Necrosis Factor-alpha | 2017 |
Statins for slowing kidney disease progression: an as yet unproven indication.
Topics: Chronic Disease; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Pravastatin; Treatment Outcome | 2008 |
Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis.
Topics: Animals; Bile Acids and Salts; Cholestasis; Cholesterol; Chronic Disease; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Homeostasis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Male; Membrane Transport Proteins; Permeability; Pravastatin; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Transcription Factors | 2011 |
Prevention of chronic rejection by pravastatin in a rat kidney transplant model.
Topics: Animals; Carrier Proteins; Chronic Disease; Cytokines; DNA-Binding Proteins; Graft Rejection; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Immunoglobulin M; Isoantibodies; Kidney; Kidney Transplantation; Male; Pravastatin; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transcription Factors | 2002 |
Poststroke emotional incontinence and decreased sexual activity.
Topics: Acute Disease; Affective Symptoms; Chronic Disease; Crying; Female; Follow-Up Studies; Humans; Laughter; Libido; Male; Middle Aged; Pravastatin; Recovery of Function; Sexual Behavior; Sexual Dysfunction, Physiological; Stroke | 2002 |